JPRN-UMIN000012576Completed未知
Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial - Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine0 sites50 target enrollmentStarted: December 14, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients meeting one of the following conditions will be excluded: 1) severe liver dysfunction 2) renal dysfunction (<Cre 2.0mg/dL) 3) severe heart failure (NYHA/New York Heart Association stage III or severer) 4) malignancies or other diseases with poor prognosis 5) pregnant, lactating, and possibly pregnant women and those planning to become pregnant 6) past medical history of hypersensitivity to investigational drugs 7) judged as ineligible by clinical investigators
Investigators
Similar Trials
Completed
Phase 4
Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT TrialCoronary Artery Disease ProgressionNCT03192579Kobe University50
Completed
Phase 2
The effect of Rosuvastatin on Carpal tunnel SyndromeCarpal tunnel syndromeIRCT2017022732799N1Shiraz University of Medical Sciences50
Not yet recruiting
Unknown
A randomized comparaTive study Of rosuvastatin/ezetimibe 20/10mg and atorvastatin/ezetimibe 40/10mg in patients with coronary artery drug eLuting stEnt implantation Requiring high-dose stAtin/ezetimibe combiNaTion therapy: TOLERANT TrialKCT0008362Yonsei University Yongin Severance Hospital200
Recruiting
Phase 3
A clinical trial to investigate the efficiency of rosuvastatin in acute cardiomyopathy induced anthracyclineCardiomyopathyIRCT2016121213090N3Vice chancellor for research of Mazandaran University of Medical Sciences80
Recruiting
Not Applicable
Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headachesMigraine headaches.MigraineIRCT20180114038369N1Ghoum University of Medical Sciences40